Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study-Reference-Cited by-同舟云学术

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Published:2016-01 Issue:1 Volume:16 Page:43-52
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Mills Anthony,Arribas Jose R,Andrade-Villanueva Jaime,DiPerri Giovanni,Van Lunzen Jan,Koenig Ellen,Elion Richard,Cavassini Matthias,Madruga Jose Valdez,Brunetta Jason,Shamblaw David,DeJesus Edwin,Orkin Chloe,Wohl David A,Brar Indira,Stephens Jeffrey L,Girard Pierre-Marie,Huhn Gregory,Plummer Andrew,Liu Ya-Pei,Cheng Andrew K,McCallister Scott

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference39 articles.

1. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system;Gupta;AIDS Patient Care STDS,2008

2. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients;Mocroft;AIDS,2010

3. Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

4. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents;Bedimo;AIDS,2012

5. Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials;Sax;Lancet,2015

Cited by 250 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments;Gastrointestinal Disorders;2024-09-12

2. Comparative Metabolic Effects of Integrase Inhibitor and Emtricitabine-Containing Tenofovir Derivatives in People Living with HIV: A Multi-Center Retrospective Analysis;2024-08-09

3. Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial;The Lancet Regional Health - Western Pacific;2024-08

4. Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility;Journal of Personalized Medicine;2024-07-26

5. Clinical considerations when switching antiretroviral therapy;Expert Review of Clinical Pharmacology;2024-06-17